Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, January 21, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Mike Matson Maintained (ZBH) at Strong Buy with Decreased Target to $155 on, Jan 21st, 2022
Mike Matson of Needham, Maintained "Zimmer Biomet Holdings, Inc." (ZBH) at Strong Buy with Decreased Target from $158 to $155 on, Jan 21st, 2022.
Mike has made no other calls on ZBH in the last 4 months.
There are 13 other peers that have a rating on ZBH. Out of the 13 peers that are also analyzing ZBH, 6 agree with Mike's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Ryan Zimmerman of "BTIG" Downgraded from Strong Buy to Hold on, Monday, January 10th, 2022
- Cecilia Furlong of "Morgan Stanley" Downgraded from Buy to Hold and Decreased Target to $145 on, Friday, January 7th, 2022
- Matt O'Brien of "Piper Sandler" Downgraded from Buy to Hold and Decreased Target to $135 on, Tuesday, January 4th, 2022
- Shagun Singh of "RBC Capital" Initiated at Hold and Held Target at $140 on, Friday, December 10th, 2021
- David Toung of "Argus Research" Downgraded from Strong Buy to Hold on, Tuesday, November 23rd, 2021
- Pito Chickering of "Deutsche Bank" Maintained at Hold with Decreased Target to $140 on, Friday, November 5th, 2021
These are the ratings of the 7 analyists that currently disagree with Mike
- Larry Biegelsen of "Wells Fargo" Downgraded from Buy to Sell and Decreased Target to $124 on, Wednesday, January 19th, 2022
- Richard Newitter of "Truist Securities" Maintained at Strong Buy with Decreased Target to $145 on, Tuesday, December 21st, 2021
- Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Decreased Target to $150 on, Wednesday, December 15th, 2021
- Jason Wittes of "Loop Capital" Initiated at Strong Buy and Held Target at $165 on, Tuesday, December 7th, 2021
- David Turkaly of "JMP Securities" Maintained at Buy with Decreased Target to $175 on, Friday, November 5th, 2021
- Anthony Petrone of "Jefferies" Maintained at Strong Buy with Decreased Target to $175 on, Friday, November 5th, 2021
- Travis Steed of "Barclays" Maintained at Buy with Decreased Target to $186 on, Tuesday, October 5th, 2021
